In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Altimmune Inc (NASDAQ: ALT) closed at $4.08 in the last session, down -0.73% from day before closing price of $4.11. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 2.96 million shares were traded. ALT stock price reached its highest trading level at $4.1699 during the session, while it also had its lowest trading level at $4.01.
Ratios:
We take a closer look at ALT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.Stifel initiated its Buy rating on January 08, 2025, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 330916544 and an Enterprise Value of 182677456. For the stock, the TTM Price-to-Sale (P/S) ratio is 16546.00 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 9133.872 whereas that against EBITDA is -1.863.
Stock Price History:
The Beta on a monthly basis for ALT is 0.00, which has changed by -0.3799392 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -23.37%, while the 200-Day Moving Average is calculated to be -35.10%.
Shares Statistics:
According to the various share statistics, ALT traded on average about 5.66M shares per day over the past 3-months and 3300430 shares per day over the past 10 days. A total of 81.11M shares are outstanding, with a floating share count of 80.26M. Insiders hold about 1.04% of the company’s shares, while institutions hold 47.57% stake in the company. Shares short for ALT as of 1752537600 were 28097407 with a Short Ratio of 4.97, compared to 1749772800 on 24400612. Therefore, it implies a Short% of Shares Outstanding of 28097407 and a Short% of Float of 34.910000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 8.0 analysts. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.24 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$0.86 and -$1.38 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.46, with 6.0 analysts recommending between -$0.99 and -$1.89.
